Basit öğe kaydını göster

dc.contributor.authorSarikaya, Meryem Kececi
dc.contributor.authorYaglioglu, Ayse Sahin
dc.contributor.authorCeylan, Mustafa
dc.contributor.authorYirtici, Uemit
dc.date.accessioned2025-03-28T07:23:36Z
dc.date.available2025-03-28T07:23:36Z
dc.date.issued2025
dc.identifier.issn1612-1872
dc.identifier.issn1612-1880
dc.identifier.urihttps://doi.org/10.1002/cbdv.202401980
dc.identifier.urihttps://hdl.handle.net/20.500.12450/6154
dc.description.abstractThe target benzothiazole derivatives (8a-g) were synthesized starting from norbornene. The addition of dichloroketene to norbornene followed by the reduction of chlorine atoms were synthesized tricyclo[4.2.1.02,5]non-7-en-3-one (4). The condensation of benzaldehyde derivatives with compound 4 were obtained chalcone analogs (6a-g). Finally, benzothiazole derivatives (8a-g) were obtained by the reaction of the chalcone analogs with 2-aminobenzothiol in an acidic medium. The antiproliferative activities of compounds 6a-g and 8a-g were determined against C6 (rat brain tumor) and HeLa (human cervical carcinoma) cell lines using a BrdU cell proliferation ELISA assay with 5-fluorouracil (5-FU) as a standard. In both series, when compared with 5-FU (IC50=3.8 mu M for C6 and 16.33 mu M for HeLa), the most active compounds against C6 cells were 6a and 8g with IC50 values of 14.13 mu M and 29.99 mu M, respectively. With this, 6a, 6e, 6f, and 8b were the most active compounds against HeLa cells with IC50 values of 0.8, 1.21, 19.33 and 18.13 mu M, respectively. Additionally, the SwissADME online web tool was used to predict the physicochemical and ADME properties of the tested compounds. The results showed that all compounds possess promising predicted physiochemical and pharmacokinetic properties and comply with Lipinski's rule of 5, indicating that they are predicted to be orally bioavailable that they possess a predicted bioavailability score of 0.55. Furthermore, in the SwissADME Boiled-Egg chart, all compounds showed high predicted GIT absorption, while compounds 6a-g showed blood-brain barrier (BBB) permeation, and compounds 8a-g did not. Moreover, none of the compounds was (P-gp) substrates. This study investigated the potential interactions between the antiapoptotic proteins Bcl-2, Bcl-xl, Bcl-w, Brag-1, Bfl-1, and Mcl-1 and compounds 6a, 8b, and 8g through molecular docking studies. The findings suggest that these compounds may effectively inhibit antiapoptotic proteins, as evidenced by significant hydrogen bonds and hydrophobic interactions, particularly with Bcl-xl.en_US
dc.description.sponsorshipDepartment of Chemistry at Gaziosmanpasa University; TUBITAK (Scientific and Technological Council of Turkey) [111T111]en_US
dc.description.sponsorshipThe authors are indebted to the Department of Chemistry at Gaziosmanpasa University and the TUBITAK (Scientific and Technological Council of Turkey) (Project No. 111T111) for their support.en_US
dc.language.isoengen_US
dc.publisherWiley-V C H Verlag Gmbhen_US
dc.relation.ispartofChemistry & Biodiversityen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject2-alkylsubstitedbenzo[d]thiazolesen_US
dc.subjectAntiproliferative activityen_US
dc.subjectHeLaen_US
dc.subjectC6en_US
dc.subjectADME predictionen_US
dc.subjectin silicoen_US
dc.titleNovel Tricyclo[4.2.1]Nonane and Bicyclo[2.2.1]Heptane Derivatives: Synthesis, in Vitro Biological Activities and in Silico Studiesen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.authoridCeylan, Mustafa/0000-0002-9184-4385
dc.identifier.volume22en_US
dc.identifier.issue2en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85209099750en_US
dc.identifier.doi10.1002/cbdv.202401980
dc.department-temp[Sarikaya, Meryem Kececi; Ceylan, Mustafa] Tokat Gaziosmanpasa Univ, Dept Chem, TR-60250 Tokat, Turkiye; [Yaglioglu, Ayse Sahin] Amasya Univ, Tech Sci Vocat Sch, Dept Chem & Chem Proc Technol, TR-05186 Amasya, Turkiye; [Yirtici, Uemit] Kirikkale Univ, Dept Med Lab, TR-71450 Kirikkale, Turkiyeen_US
dc.identifier.wosWOS:001356818800001en_US
dc.identifier.pmid39400495en_US
dc.snmzKA_WOS_20250328
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster